Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

BACKGROUND: A 31-gene expression profile (GEP) test that provides risk classification of cutaneous melanoma (CM) patients has been validated in several retrospective studies. The objective of the reported study was a prospective evaluation of the GEP performance in patients enrolled in two clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsueh, Eddy C., DeBloom, James R., Lee, Jonathan, Sussman, Jeffrey J., Covington, Kyle R., Middlebrook, Brooke, Johnson, Clare, Cook, Robert W., Slingluff, Craig L., McMasters, Kelly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576286/
https://www.ncbi.nlm.nih.gov/pubmed/28851416
http://dx.doi.org/10.1186/s13045-017-0520-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576286/
https://www.ncbi.nlm.nih.gov/pubmed/28851416
http://dx.doi.org/10.1186/s13045-017-0520-1

Ejemplares similares